Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Results from new collaboration between Alfacell and University of Frankfurt

Jan. 31, 2002

Compounds useful in hyperproliferative disorders claimed by Pfizer

Jan. 30, 2002

Sugen claims compounds that modulate protein kinases and phosphatases

Jan. 30, 2002

MG-98 enters clinical trials in MDS and AML

Jan. 30, 2002

Novel caspase inhibitors identified at Vertex

Jan. 29, 2002

Schering AG and Mologen to develop cell-based therapies

Jan. 29, 2002

Iressa under regulatory review in two major markets for NSCLC

Jan. 29, 2002

Human Genome Sciences submits IND for B-cell-targeting LymphoRad

Jan. 28, 2002

Cell Pathways updates phase IIa program of CP-461 in cancer

Jan. 28, 2002

Tubulin-binding agents from AstraZeneca with antiangiogenic activity

Jan. 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...